Salivary Carriage of ESBL-Producing Coliforms in Root Canal Therapy Patients and Its Association with Antibiotic Use: A Brief Study
DOI:
https://doi.org/10.22100/ijhs.v12i2.1300Keywords:
Extended-spectrum beta-lactamase, Coliform bacteria, Root canal therapy, Antibiotic resistance, Oral microfloraAbstract
Background: Saliva serves as a noninvasive medium for detecting extended-spectrum beta-lactamase (ESBL)-producing coliforms in patients undergoing root canal treatment (RCT). These bacteria have the potential to transfer antibiotic resistance genes to native oral biofilm microbes. Therefore, this study was done to check the presence of ESBL-producing coliform bacteria in the saliva of patients undergoing RCT and to explore their association with recent antibiotic use.
Methods: The study was conducted in a Dental College and Hospital located in the capital city of an eastern Indian state. Two millilitres of unstimulated saliva were collected from 20 patients undergoing RCT. Saliva samples were routinely processed using standard microbiological methods to identify bacteria, and the double-disk synergy test was used to confirm ESBL strains.
Results: Of the 20 saliva samples collected, 40% of the strains were identified as coliform bacteria. Furthermore, 3 of the 8 coliform isolates were identified as ESBL strains. ESBL colonisation showed a statistically significant association with prior antibiotic use (P-value=0.0079).
Conclusion: This pilot study suggests that coliform and ESBL-producing bacteria may colonise the oral cavity of patients undergoing endodontic treatment; however, the findings should be interpreted cautiously due to the small sample size. These results highlight the importance of strict antibiotic stewardship in dental settings to limit the emergence and spread of resistant strains.
References
Rawat D, Nair D. Extended-spectrum β-lactamases in Gram-negative Bacteria. J Glob Infect Dis. 2021;13(1):27-36.
Bassetti M, Righi E, Carnelutti A. Antimicrobial resistance in the next 30 years, humankind, bugs, and drugs: a visionary approach. Int J Antimicrob Agents. 2022;60(1):106591.
Kawayanagi T, Kawada-Matsuo M, Takeshita T, Le MN, Asakawa M, Sugawara Y, Arai C, Ouhara K, Nishi H, Mizuno N, Kawaguchi H, Shiba H, Sugai M, Komatsuzawa H. The oral cavity is a potential reservoir of Gram-negative antimicrobial-resistant bacteria, which are correlated with ageing and tooth count. Heliyon. 2024;10(21): e39827. doi: 10.1016/j.heliyon.2024.e39827
Søraas A, Olsen I, Sundsfjord A, Handal T, Bjørang O, Jenum PA. Extended-spectrum beta-lactamase-producing bacteria are not detected in supragingival plaque samples from human faecal carriers of ESBL-producing Enterobacteriaceae. J Oral Microbiol. 2014;6. doi: 10.3402/jom.v6.24026
Rath S, Bal SCB, Dubey D. Oral Biofilm: Development Mechanism, Multidrug Resistance, and Their Effective Management with Novel Techniques. Rambam Maimonides Med J. 2021;12(1): e0004. doi: 10.5041/RMMJ.10428
Mohanty M, Govind S, Rath S. Prevalence of salivary microbial load and lactic acid presence in diabetic and non-diabetic individuals with different dental caries stages. Restor Dent Endod. 2024;49(1): e4. doi: 10.5395/rde.2024.49.e4
Clinical & Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 34th ed. Wayne (PA): Clinical & Laboratory Standards Institute; 2024.
Rath S, Padhy RN. Prevalence of two multidrug-resistant Klebsiella species in an Indian teaching hospital and adjoining community. J Infect Public Health. 2014;7(6):496-507. doi: 10.1016/j.jiph.2014.05.002
Alghamdi S, Almutairi M, Alotaibi F, et al. The Impact of Antibiotics on Oral Microbiota and Antibiotic Resistance Genes in Dental Settings. Antibiotics (Basel). 2022;11(10):1389.
Gupta A, Yadav P, Mehta P. Evaluation of ESBL-producing organisms from saliva in systemically healthy subjects: An emerging oral threat. J Indian Soc Periodontol. 2023;27(2):163-168.
Câmara DS, de Oliveira VM, do Nascimento C et al—antibiotic resistance in oral biofilms: an ecological and clinical perspective. Arch Oral Biol. 2022; 134:105364.
Published
Issue
Section
License
The Copyright Form should be downloaded and signed by corresponding author in the fourth step "upload supplementary files" during submission process.
After acceptance, copyright form should be downloaded and signed by all authors one by one ( "summery --> supp. file" part and click on "add a supplementary file" link).
https://orcid.org/0000-0003-3249-9080

